Document is current
Any future updates will be listed below
-
Authors
Martín Pérez, Carla
Aguilar, Ruth
Jiménez, Alfons
Salmerón, Gemma
Canyelles, Mar
Rubio, Rocío
Vidal, Marta
Cuamba, Inocencia
Barrios, Diana
Díaz, Natalia
Santano, Rebeca
Serra, Pau
Santamaria, Pere
Izquierdo, Luis
Trilla, Antoni
Vilella, Anna
Barroso, Sonia
Tortajada, Marta
García-Basteiro, Alberto L.
Moncunill, Gemma
Dobaño, Carlota http://orcid.org/0000-0002-6751-4060
-
Funding
Funding for this research was provided by:
Fundació Privada Daniel Bravo Andreu
European Union (101046314)
ISGlobal
Hospital Clinic de Barcelona
Departament de Salut, Generalitat de Catalunya (PERIS SLT017/20/000224)
Ministerio de Ciencia e Innovación (CEX2018-000806-S, PID2021-125493OB-I00)
AGAUR (100046TC21_ 2022 INV-1 00046)
European Social Fund (RYC 2020-538 029886-I/AEI/10.13039/501100011033)
- License Information
-
More Information
Article History
Received: 2 November 2023
Accepted: 13 February 2024
First Online: 8 March 2024
Declarations
:
: Written informed consent was obtained from all study participants prior to study initiation. The study was approved by the Ethics Committee at HCB (references HCB/2020/0336 and HCB/2021/0196).
: Not applicable.
: P. Santamaria is founder, scientific officer, and stock holder of Parvus Therapeutics and receives funding from the company. The other authors declare no competing interests.
